Bitcoin vs Injective — how do they compare? Bitcoin trades at Rp1,117,210,084 (market cap Rp22.380,97T, Rp375,81T 24h volume), while Injective trades at Rp78,615 (market cap Rp7,84T, Rp671,51M 24h volume). The key difference: Bitcoin is far larger — about 2854.7× Injective's market cap, and Bitcoin's supply is capped (20,1M / 21M BTC (96%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bitcoin for 107 Days and Injective for 37 Days on average.
| BTC | INJ | |
|---|---|---|
Market Cap | Rp22.380,97T | Rp7,84T |
Volume (24h) | Rp375,81T | Rp671,51M |
Circulating Supply | 20,1M / 21M BTC (96%) | 100M INJ |
Typical Hold Time | 107 Days | 37 Days |
Signals from Pluang's Aura AI — not financial advice
Bitcoin is currently trading at Rp1,116,250,000 with a bearish technical signal as moving averages show strong selling pressure while oscillators remain neutral. The asset is trading near key support levels with RSI_6 at 24.02 indicating potential oversold conditions. Recent market sentiment reflects caution amid a 50% decline from October 2025 highs, though long-term projections remain optimistic with some analysts targeting Rp15.3 trillion ($1 million equivalent) by 2030.
Overall outlook remains cautious short-term due to technical bearishness, but long-term fundamentals remain intact with 96% circulation rate and strong HODLer behavior (107-day average hold time). Key opportunities include potential oversold bounce and institutional adoption through recent acquisitions. Major risks include continued technical weakness, regulatory uncertainty, and high volatility characteristic of crypto markets.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
What Pluang investors did over the last 30 days
Latest headlines on both assets
A crypto asset founded in January 2009 by Satoshi Nakamoto. It is the first and most widely used decentralized online currency with the highest market capitalization. Its purpose is to provide a peer-to-peer payment system without the need of third party. The total supply of BTC is limited and pre-defined at 21 million. As of October 2020, there are more than 85% of BTC in circulation.
Read more on BTC →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →